SA Pathology
SA Pathology is South Australia's state-wide public pathology service, providing comprehensive diagnostic testing across 100+ collection centres and serving 75% of the state's pathology requirements with bulk-billed Medicare services.
- Company typePrivate
- Founded1938
- HeadquartersAdelaide, Australia
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What SA Pathology does
SA Pathology is South Australia's state-wide public pathology service, operating as a not-for-profit government-owned entity within Statewide Clinical Support Services (SCSS) under SA Health. Founded in 1938 as the Institute of Medical and Veterinary Science (IMVS) and renamed in 2008 following amalgamation with Women's and Children's Hospital Pathology and Southern Pathology, the organization holds approximately 75% of South Australia's pathology market share and touches 50% of the state's population annually. It delivers comprehensive diagnostic testing across anatomical pathology, chemical pathology, genetics and molecular pathology, haematology, immunology, and microbiology and infectious diseases, supported by specialized reference laboratories including a WHO-recognized Supranational TB Reference Laboratory, the Australian Salmonella Reference Centre, the National Mycology Reference Centre, and a Leukaemia Unit.
The service operates through a distribution network of over 100 collection centres spanning metropolitan Adelaide and regional South Australia, supplemented by hospital-based laboratories at Royal Adelaide, Flinders Medical Centre, Lyell McEwin, Women's and Children's, Queen Elizabeth, and Modbury hospitals, plus home-based domiciliary visits for mobility-impaired patients and online booking at 14+ centres. Results delivery is handled via the iPath web portal and EDI integrations with clinical software (Medical Director, Best Practice, Genie, Zedmed). Technology differentiators include NATA/NPAAC ISO 15189-accredited genomic sequencing (clinical exome, whole genome, somatic panels), cytogenomics, and a catalogue of 4,500+ diagnostic tests. Patient experience innovations include Smileyscope VR and BUZZY pain-distraction devices at paediatric collection centres, achieving 98% patient approval ratings.
The business model is anchored in Medicare bulk-billing (no out-of-pocket cost for eligible patients), with supplementary revenue from fee-for-service non-Medicare tests, private health insurance billing, interstate hospital referrals (at 125% of MBS fee), commercial drug and alcohol workplace testing, food and environmental laboratory services, and research/clinical trial fee-for-service testing. Research output is substantial, with 80+ active grants and contracts through the Centre for Cancer Biology (alliance with University of South Australia) and Hanson Institute (partnership with Royal Adelaide Hospital). Customer segments span the SA public health system (GPs, hospitals, Local Health Networks), individual patients, pregnant women and families (via SAMSAS, NIPT, newborn screening, reproductive carrier testing), specialist practitioners, commercial businesses (food safety, aged care), and research institutions.
SA Pathology firmographics
Firmographics- Name
- SA Pathology
- Legal name
- SA Pathology
- Website
- https://sapathology.sa.gov.au
- Company type
- Private
- Founded year
- 1938
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- SA Pathology is South Australia's state-wide public pathology service, providing comprehensive diagnostic testing across 100+ collection centres and serving 75% of the state's pathology requirements with bulk-billed Medicare services.
- Ownership category
- akta.pro rank
SA Pathology industry classification
Industry- Product category
- Diagnostic Pathology Services
- NAICS
- Medical Laboratories (621511), Scientific Research and Development Services (5417)
- SIC
- Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
- akta.pro secondary industries
- Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays) (HLAAALAI), Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Anatomic Pathology & Histopathology (Trial Support) (HLAGAEAC)
Keywords
Where SA Pathology is headquartered
LocationHeadquarters
- HQ city
- Adelaide
- HQ country
- Australia
- HQ region
- Oceania
Offices10 records
Markets served
SA Pathology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain, Others
Revenue model
- Medicare Bulk-Billing: SA Pathology bulk-bills Medicare for all items covered by Medicare, meaning most patients incur no out-of-pocket expenses. This is the primary revenue stream as a not-for-profit public healthcare organisation.
- Fee-for-Service Testing: Revenue from tests or services not funded by the Commonwealth which do not have a Medicare item number. Patients receive invoices for non-Medicare listed tests and must complete an Agreement to Pay form.
- Private Health Insurance Billing: Private inpatients and day stay patients are billed through private health insurers where possible, or invoiced directly for presentation to Medicare and private health insurer.
- Commercial Drug and Alcohol Testing: Workplace drug and alcohol testing services for commercial organisations including confirmation testing, with collection services at accredited collection centres.
- Food and Environmental Testing Services: Microbiological and chemical testing services for commercial industries, local businesses, and government agencies for food safety, water quality, and environmental compliance.
- Research and Clinical Trial Testing: Fee-for-service analysis of samples for clinical trials, research projects, and commercial purposes at competitive rates.
- Interstate Hospital Referrals: Interstate hospitals and approved pathology providers referring tests to SA Pathology are invoiced at 125% of MBS fee, with non-MBS tests billed at 125% of SA Pathology Pathology Collection Guide fees.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | Standard Medicare-Bulk-Billed Tests |
| One time/ perpetual license | Pay-as-you-go | Non-Medicare Tests |
| Other | Multi-year contract | Research and Commercial Testing |
| Subscription | Pay-as-you-go | Reproductive Carrier Testing |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels6 records
SA Pathology product offering
Product offeringCore offering
SA Pathology is South Australia's state-wide public pathology provider delivering comprehensive diagnostic testing across anatomical pathology, chemical pathology, genetics and molecular pathology, haematology, immunology, microbiology, and infectious diseases. Services are accessed through a network of 80+ collection centres, hospital laboratories, and home-based domiciliary visits, with results delivered electronically via the iPath portal and EDI software. Specialised offerings include newborn screening, maternal serum screening, NIPT, reproductive carrier testing, reference laboratory services, commercial drug/alcohol testing, and food/environmental testing.
Product overview
SA Pathology is South Australia's state-wide public pathology service operating as a unified platform with multiple integrated components. The core service provides diagnostic pathology testing through a network of over 100 collection centres across metropolitan and regional South Australia, supported by specialist laboratories including Genetics and Molecular Pathology (GMP), the Mycobacterium Reference Laboratory, Australian Salmonella Reference Centre, National Mycology Reference Centre, and Leukaemia Unit. Patient-facing offerings include SAMSAS (maternal serum screening), the Newborn Bloodspot Screening Program, Non-Invasive Pregnancy Testing (NIPT/Nest), Reproductive Carrier Testing, and Respiratory Testing. Results are delivered through the iPath web portal and EDI software integration with clinical systems. Commercial services encompass Drug and Alcohol Testing and the Food and Environmental Laboratory. Supporting patient experience tools include Smileyscope VR and BUZZY for paediatric needle procedures.
Differentiator
Problem solved
Functional benefit
Products and services
- Genetics and Molecular Pathology (GMP) NATA/NPAAC (ISO 15189) accredited genetic testing laboratory offering clinical exome and whole genome sequencing for inherited conditions, and somatic sequencing for solid tumours and haematological malignancies using targeted next-generation sequencing panels. Serves clinicians across South Australia and interstate referrals.
- Newborn Bloodspot Screening Program State-wide screening for over 30 metabolic, endocrine, haematological, and genetic disorders using a blood sample collected within 48-72 hours of birth. Provided to all newborns in South Australia.
- SAMSAS (Maternal Serum Antenatal Screening) Accredited laboratory service providing comprehensive risk assessment for Down syndrome (trisomy 21), other autosomal aneuploidies, and open neural tube defects during pregnancy.
- Non-Invasive Pregnancy Testing (NIPT/Nest) First-trimester prenatal screening using whole genome sequencing of cell-free DNA to determine chance of chromosome conditions such as Trisomy 21, 13, and 18, performed from 10 weeks gestation.
- Reproductive Carrier Testing Genetic testing for Cystic Fibrosis (CF), Spinal Muscular Atrophy (SMA), and Fragile X Syndrome (FRAX) carrier status, bulk-billed for eligible Medicare patients planning or currently pregnant. From 1 November 2023, bulk-billing applies for initial and follow-up partner testing.
- Omega-3 Status Testing Blood testing for omega-3 status in pregnant women to assess preterm birth risk, offered in collaboration with SAHMRI as a world-first free program based on 20 years of research. Has tested around 37,000 pregnant women since 2021.
- Self-Collect Cervical Screening HPV self-collection option for cervical screening, available to women aged 25 years or older who need HPV testing and have a cervix (excluding pregnant women), with GP referral.
- Respiratory PCR Testing PCR testing for respiratory pathogens including influenza A & B, RSV, metapneumovirus, parainfluenza, adenovirus, rhinovirus, Mycoplasma, Bordetella pertussis, and COVID-19, with self-collect and collection centre options.
- Mycobacterium Reference Laboratory WHO-recognised Supranational TB Reference Laboratory providing diagnostic and reference services for tuberculosis and non-tuberculosis mycobacteria, including whole genome sequencing for cluster investigations and AMR detection. Provides education and technical support to National Reference Laboratories in Kiribati, Solomon Islands, Vietnam, and Indonesia.
- Australian Salmonella Reference Centre National reference centre providing serotyping, biotyping, and molecular subtyping services for Salmonella identification in human, animal, food, and environmental isolates for public health surveillance. Runs the ANZERN National Proficiency Testing program in Salmonella serotyping.
- National Mycology Reference Centre National referral centre providing mycology testing services including fungal microscopy, culture, susceptibility testing, dermatophyte PCR, and expert advice on fungal diagnostics. Delivers the Mycology Masterclass course nationally.
- Leukaemia Unit National referral laboratory for characterisation of rare gene fusion transcripts in CML patients with atypical molecular profiles, and one of few Australian laboratories performing drug resistance mutation testing.
- National Referral Laboratory for Rare Inherited Metabolic Conditions Centre of excellence for diagnostic testing of lysosomal storage disorders, peroxisomal disorders, and other rare inherited metabolic conditions, providing biochemical screens, enzyme analyses, and molecular testing through the Genomics Unit.
- Drug and Alcohol Testing Workplace drug and alcohol testing service with collection services at accredited collection centres, detecting controlled and illegal substances per Australian toxicology standards, with local confirmation testing in Adelaide. NATA certified.
- Food and Environmental Laboratory Microbiological and chemical testing for foods, beverages, waters, cosmetics, and pharmaceutical products for harmful bacteria including Salmonella, Listeria, Campylobacter, E. coli, and Legionella programs for water systems. NATA accredited.
- Antibiotic Susceptibility Testing Antimicrobial susceptibility testing following EUCAST guidelines, providing susceptible and resistant results with dosage tables for standard, high dose, and uncomplicated UTI dosing recommendations.
- iPath Results Platform Web-based pathology result delivery solution providing clinicians access to pathology results with enhanced search functionality for finding patient results across the public hospital system.
- Collection Centre Network Service State-wide network of over 80 collection centres across metropolitan Adelaide and regional South Australia, offering general pathology plus specialised paediatric, STI screening, ECG, urine drug screening, and venesections services.
- Domiciliary Visit Service Home-based blood collection service for patients unable to attend collection centres, including recently discharged hospital patients, mobility-impaired individuals, and residential aged care facility residents, with doctor referral.
- Smileyscope VR Patient Experience Service Virtual reality headset service offering relaxing VR and meditation programs with evidence-based music therapy to distract paediatric patients from needle procedures, available at select paediatric collection centres.
- BUZZY Pain Distraction Service Pain management service using nerve stimulation and mental distraction with ice-pack wings and vibrations based on the gate control theory of pain, awarded 98% approval rating from SA Pathology patients.
Quantifiable outcome
- 50% of South Australia's population served annually
- +5 more outcomes
Companies that use SA Pathology
Customer profileNamed customers10 records
Segments6 records
Ideal customer profiles5 records
SA Pathology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
Feature11 records
SA Pathology partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- South Australian Health and Medical Research Institute (SAHMRI)coreCollaboration on world-first free omega-3 testing program for pregnant women to prevent preterm birth. Based on 20 years of research, the program will introduce free omega-3 blood tests from June 1 for pregnant women with singleton pregnancies before 20 weeks' gestation. SAHMRI researchers found direct link between low omega-3 levels and preterm delivery risk.
- University of South Australia (UniSA)coreAlliance to operate the Centre for Cancer Biology, an internationally recognised cancer research centre hosting over 20 group leaders and teams. Research teams actively form alliances with pharmaceutical companies to foster knowledge and advance new treatments.
- Royal Adelaide HospitalcoreResearch partnership through the Hanson Institute, established in 1991 as an internationally recognised research partnership between SA Pathology and the Royal Adelaide Hospital, working in close collaboration with other South Australian medical research organisations.
- Women's and Children's Health NetworkcorePartnership providing specialist pathology services including paediatric pathology, perinatal pathology, and women's health diagnostics. SA Pathology operates collection centre and laboratories at Women's and Children's Hospital site.
- Central Adelaide Local Health Network (CALHN)corePathology services partnership providing diagnostic testing to Royal Adelaide Hospital and associated facilities within the Central Adelaide Local Health Network.
- Southern Adelaide Local Health Network (SALHN)corePathology services partnership providing diagnostic testing to Flinders Medical Centre, Flinders Private Hospital, and associated SALHN facilities.
- Northern Adelaide Local Health Network (NALHN)corePathology services partnership providing diagnostic testing to Lyell McEwin Health Service and associated NALHN facilities.
- Regional Local Health NetworkscorePartnerships with regional hospitals including Barmera, Berri, Ceduna, Clare, Port Augusta, Port Lincoln, Port Pirie, Murray Bridge, Wallaroo, Whyalla, Mount Gambier, and Victor Harbor for pathology collection and testing services.
- University of AdelaideminorHistorical partnership through Institute of Medical and Veterinary Science (IMVS) with strong historical links to University of Adelaide for pathology training and medical research.
- Statewide Clinical Support Services (SCSS)coreSA Pathology is a member of Statewide Clinical Support Services (SCSS), a public healthcare organisation serving health consumers and providing specialist clinical services to the health system in South Australia.
- SA HealthcorePrimary government health partner for state-wide pathology services, food and environmental testing, and public health response during disease outbreaks and food/environmental threats.
Scale indicators8 records
Recent moves8 records
Expansion highlights5 records
SA Pathology competitors and assessment
Company assessmentDirect peers
- Australian Clinical Labs: ASX-listed national pathology operator providing comprehensive diagnostic testing to GPs, specialists, and hospitals across Australia. Highly comparable to SA Pathology in test menu breadth (anatomical, chemical, genetics, microbiology) and customer base, though privately listed and commercially operated.
- Sonic Healthcare: Australia's largest private pathology operator with a national network of laboratories and collection centres. Directly comparable business model to SA Pathology (diagnostic testing across all pathology disciplines, hospital and GP referrals, NATA-accredited), but operates commercially across multiple states rather than as a single-state public monopoly.
- PathWest: Western Australia's state public pathology service, operating laboratories and collection centres across metropolitan and regional WA. Closely comparable to SA Pathology as a state-government public pathology operator offering comprehensive diagnostic testing, reference lab functions, and forensic services.
- NSW Health Pathology: State-wide public pathology service for New South Wales operating under NSW Health, providing diagnostic testing across metropolitan and regional NSW. Functionally equivalent peer to SA Pathology in mandate, governance structure, and service scope (hospital labs, collection centres, reference laboratories, public-health response).
- Healius: Major ASX-listed Australian pathology operator (formerly Primary Health Care) running a national network of laboratories and collection centres. Directly comparable to SA Pathology in offering routine and specialised pathology, with a similar broad test menu and hospital/GP customer base, but with commercial reach across states.
Broad incumbents
- ARUP Laboratories: US-based nonprofit clinical and reference laboratory owned by University of Utah, specialising in esoteric and complex diagnostic testing. Highly comparable to SA Pathology's specialised reference lab functions (TB, Salmonella, mycology, leukaemia) and academic/research integration model.
- Quest Diagnostics: One of the world's largest clinical laboratory networks, providing routine and advanced diagnostic testing with significant reference laboratory capability. Comparable to SA Pathology in broad test menu and clinical trial support services, though global in scale and US-listed.
- LabCorp: Global clinical laboratory giant offering routine and esoteric diagnostic testing across North America and internationally. Comparable to SA Pathology's full-service clinical diagnostics and reference laboratory functions (specialised genetics, microbiology, oncology), though operating at vastly greater scale and as a commercial entity.
Regional players
- Victorian Clinical Genetics Services: Victorian public genetics and genomics service (part of Murdoch Children's Research Institute) offering reproductive carrier screening, NIPT, and clinical genetics. Comparable to SA Pathology's genetics and molecular pathology portfolio (NIPT, reproductive carrier testing, newborn screening) but focused on genomics rather than full-service pathology.
Others
- Genomics England: UK Government-owned genomics initiative delivering whole genome sequencing at population scale for the NHS. Comparable to SA Pathology's genomics and newborn screening programs (population-scale screening, WGS infrastructure, public-health mandate) but operates at national scope and as a dedicated genomics entity rather than full-service pathology.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
SA Pathology social profiles
Digital presenceSA Pathology compliance and trust
Trust signalCompliance6 records
SA Pathology financial estimates
Financial estimateRevenue estimate
Valuation estimate
SA Pathology leadership team
Management profileNumber of profiles
Profiles7 records
SA Pathology subsidiaries and ownership
Company hierarchySubsidiaries2 records
SA Pathology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SA Pathology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SA Pathology
What does SA Pathology do?
SA Pathology is South Australia's state-wide public pathology provider delivering comprehensive diagnostic testing across anatomical pathology, chemical pathology, genetics and molecular pathology, haematology, immunology, microbiology, and infectious diseases. Services are accessed through a network of 80+ collection centres, hospital laboratories, and home-based domiciliary visits, with results delivered electronically via the iPath portal and EDI software. Specialised offerings include newborn screening, maternal serum screening, NIPT, reproductive carrier testing, reference laboratory services, commercial drug/alcohol testing, and food/environmental testing.
Is SA Pathology a public or private company?
SA Pathology is a private company. It is classified as state government owned and is currently operating.
When was SA Pathology founded?
SA Pathology was founded in 1938. It employs 1,001 to 5,000 people.
Where is SA Pathology based?
SA Pathology is headquartered in Adelaide, Australia, in the Oceania region.
How does SA Pathology make money?
Seven revenue lines are on record. Medicare Bulk-Billing is the primary driver. The others are fee-for-Service Testing, private Health Insurance Billing, commercial Drug and Alcohol Testing, food and Environmental Testing Services, research and Clinical Trial Testing and interstate Hospital Referrals.
Who are SA Pathology's main competitors?
Direct peers on record are Australian Clinical Labs, Sonic Healthcare, PathWest, NSW Health Pathology and Healius. Broad incumbents are ARUP Laboratories, Quest Diagnostics and LabCorp. Victorian Clinical Genetics Services is listed as a regional player. Genomics England is listed as an others.
Does SA Pathology have an API?
No public API is recorded for SA Pathology.
What industry is SA Pathology in?
SA Pathology's product category is Diagnostic Pathology Services. Its primary akta.pro industry code is HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays), with a secondary code of HLAAALAI, Cytology & Histopathology Diagnostics (IHC, ISH, tissue-based assays). Its NAICS code is 621511 and its SIC code is 8071.